Skip to main content Help with accessibility Skip to main navigation

Linzagolix for treating moderate to severe symptoms of uterine fibroids (NICE TA996)

CCG Approval Status:

Date Added: 23 - Oct - 2024
Body System:
Amber retained

The Cheshire and Merseyside Area Prescribing Group recommend linzagolix for treating moderate to severe symptoms of uterine fibroids in accordance with NICE TA996.

NHS Cheshire and Merseyside APPROVED